News Results
There are 793,815 News Results
Nov 17, 2017
Ecolab Inc. (“Ecolab”) (NYSE: ECL) today announced that it has commenced an offer (the “Exchange Offer”) to certain eligible holders to exchange its outstanding 5.500% Notes due 2041 (CUSIP 278865...
Nov 20, 2017
NEW YORK, Nov. 21, 2017 /PRNewswire/ -- New construction starts in October dropped 9% to a seasonally adjusted annual rate of $742.9 billion, pulling back after a 14% jump in...
Nov 27, 2017
LONDON, Nov. 28, 2017 /PRNewswire/ --
Nov 30, 2017
DUBLIN, December 1, 2017 /PRNewswire/ -- The "Electric Vehicles 2018-2038: Forecasts, Analysis and Opportunities" report has been added to
Nov 30, 2017
PLANO, Texas, Dec. 1, 2017 /PRNewswire/ -- Toyota Motor North America (TMNA) Inc., today reported November 2017 sales of 191,617 units. With the same number of selling days in November...
Dec 3, 2017
LAVAL, Quebec, Dec. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") and Valeant Pharmaceuticals International ("VPI," and together with Valeant, the "Offerors"), a wholly-owned subsidiary...
Dec 6, 2017
SILVER SPRING, Md., Dec. 7, 2017 /PRNewswire-USNewswire/ -- Today we're announcing three new, significant policy documents to advance the FDA's approach to the development and proper oversight of innovative digital...
Dec 6, 2017
SILVER SPRING, Md., Dec. 7, 2017 /PRNewswire-USNewswire/ -- Today we're announcing three new, significant policy documents to advance the FDA's approach to the development and proper oversight of innovative digital...
Dec 7, 2017
WOODCLIFF LAKE, N.J., Dec. 8, 2017 /PRNewswire/ -- Eisai Inc. today announced updated results of ENHANCE 1, a Phase 1b/2 trial investigating eribulin mesylate (marketed as HALAVEN(®), "eribulin"), in combination...
